The OAC is pleased to share that Amgen has renewed their membership on the OAC’s Chairman’s Council at the Silver level. Thank you for continuing to support the OAC’s mission!
Amgen is one of the world’s leading biotechnology companies, focused on using science and innovation to transform treatments for patients with serious diseases.
Obesity is one of the many serious diseases that Amgen recognizes and addresses through research and science-based treatment. With a sole focus on helping patients, families and communities, Amgen believes in a “biology first” approach that has the power to restore health and save lives. They hold a value-based approach which recognizes the biological component of obesity and the need to explore innovative and improved treatments that will help reduce the physical, social and economic impact of obesity in today’s society.
To learn more about Amgen, click here.
About OAC’s Chairman’s Council
The OAC is honored to have the Silver level of support of Amgen through the Chairman’s Council, as we strive to partner with industry leaders who share in our mission of supporting individuals affected by obesity through education and advocacy.
The OAC welcomes ANY individual, organization or company who wishes to join our highest level of OAC Membership and receive maximum benefits. The OAC Chairman’s Council is an excellent way to give back to our cause and play an integral role in making the world a better place for people with obesity. To learn more about the Chairman’s Council, click here.